Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer

2023 . Garrido, Rosario | Manoogian, Melissa | Ghambire, Dhiraj | Lucas, Shawn | Karnoub, Maha | Olson, Matthew T. | Hicks, David G. | Tozbikian, Gary | Prat, Aleix | Ueno, Naoto T. | Modi, Shanu | Feng, Wenqin | Pugh, Judith | Hsu, Ching | Tsurutani, Junji | Cameron, David | Harbeck, Nadia | Fang, Qijun | Khambata-Ford, Shirin | Liu, Xuemin | Inge, Landon J. | Vitazka, Patrik